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Abstract
Virilism is the masculinization and enhancement of male secondary sexual characteristics in females.
The etiology is usually of adrenal or ovarian origin. Here we report a case of virilizing Leydig cell type,
steroid cell tumor of the left ovary, in a 40 year old female who presented with clinical signs and
symptoms of virilization: deepening of voice, hirsutism (Ferriman-Gallwey score 26), clitoromegaly,
and androgenic alopecia. On further evaluation, laboratory investigations revealed hyperandrogenism
in the male range. Basal testosterone values were elevated. Folicle Stimulating Hormone and
Luteinising Hormone levels were within normal limits. Dexamethasone suppression test did not alter
cortisol or testosterone levels. An ovarian mass was confirmed radiologically. Following a total
abdominal hysterectomy with bilateral salpingoophorectomy, histopathological studies confirmed a
left sided steroid-cell ovarian tumor, Leydig cell type (stage T1N0M0), which proved to the etiology
of virilization in this patient. Post-operatively her serum testosterone levels declined with
near-complete reversal of symptoms over time.
Introduction
Hirsutism is defined as excessive male-pattern hair growth.
Virilization refers to a condition in which the androgen
levels are sufficiently high to cause additional signs and
symptoms such as deepening of the voice, breast atrophy,
increased muscle bulk, clitoromegaly, and increased libido
[1]. Virilizing ovarian tumors account for 0.1% of all
ovarian tumors [2]. Here we report a 40-year-old woman
who presented to the gynecology outpatient department
with signs and symptoms of virilization. After investiga-
tions and histopathological examination, the patient was
found to have a steroid-cell ovarian tumor, Leydig-cell
type, which proved to the etiology of virilization in this
patient.
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A 40-year-old multiparous woman from South India was
referred to our Gynecology department with a two year
history of progressive deepening of voice, an increase in
facial and body hair, and frontal balding; her symptoms
have worsened over the past six months. She attained
menarche at the age of 14 years, and has had irregular
menses lasting 3 to 4 days, every three or four months
since then. She is a mother of two healthy boys, aged 12
and 15 years, both of whom were delivered vaginally
without complications. The patient has been amenorrheic
for the past four and a half years. There is no history
suggestive of hypothyroidism or hyperprolactinemia.
There is no significant family history, other than the fact
that her mother attained menopause at the age of 40 years.
She is a known hypertensive on treatment with calcium
channel blockers. She is not on any other medications.
On examination, the patient was moderately built with a
body mass index of 25 kg/m
2. She had a low-pitched
female voice. Head and neck examination showed male-
pattern alopecia and obvious facial hair (Figure 1). There
was no thyromegaly. The patient had severe hirsuties
affecting the chest, forearms, thighs and anterior abdom-
inal wall, with a Ferriman Gallwey score of 26 [3]. She was
afebrile, with a pulse rate of 90 beats per minute and a
blood pressure of 140/86 mmHg. Chest examination
revealed bilateral breast atrophy with periareolar hair. On
abdominal examination, there were no visible striae; the
abdomen was soft, non-tender, with no obvious free fluid
or mass on palpation. Pelvic examination revealed an
enlarged clitoris (Figure 2), a nabothian follicle over the
cervix, and an anteverted, small sized uterus with bilateral
forniceal fullness. Other systems examination were
unremarkable.
Blood investigations showed a free testosterone level of
52 ng/dl and a serum total testosterone of 2300 ng/dl
(normal value: 14 - 76 ng/dl). Serum cortisol, 17-
hydroxyprogesterone, prolactin, FSH, LH, thyroid hor-
mone levels, blood sugars, and all other blood parameters
were within normal limits (Table 1). Radiological imaging
comprised of a chest x-ray, an ultrasonogram of the
abdomen, a computed tomography (CT) scan, and a
magnetic resonance imaging (MRI) scan. The chest x-ray
was normal. The ultrasound of the abdomen revealed
polycystic ovaries. The CT-scan of the abdomen and pelvis
showed a bulky uterus (7.8 × 5.6 cm) with a mass lesion
(4 × 2.1 × 3.2 cm) in the region of the fundus/left adnexa.
An MRI pelvis with contrast showed two separate, well-
defined oval lesions, each one adjacent to either internal
iliac vessel (right: 3 × 2.5 × 2.2 cm; left: 4.3 × 3 × 2.3 cm).
The lesion on the left side showed patchy enhancement
after instillation of the contrast, and was seen indenting
the uterine fundus. Both the ovaries were not visualized
separate from either lesion. In view of the patient’s age
and multiparity, the management involved a staging
laparotomy followed by total abdominal hysterectomy,
bilateral salpingoophorectomy, and infracolic omentect-
omy. The specimen was sent for histopathological
examination.
Figure 1. Androgenic alopecia and excess facial hair.
This photo shows growth of coarse hair over the face and
male pattern baldness- characteristic of virilization. Stubble is
also seen over the chin and mandibular areas. Figure 2. Clitoromegaly. An enlarged clitoris is visualized.
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brown in color, and stony hard in consistency (right: 4 × 3
cm; left: 3 × 3 cm). The right ovary revealed a uniform
solid grey-tan color covering the cut surface. The cut
surface of the left ovary showed a solid grey-tan color with
irregular grey-brown areas (Figure 3). On microscopy,
there was stromal hyperplasia of both ovaries, with the left
ovary showing a well differentiated steroid cell tumor.
Crystalloids of Reinke were seen in plenty, thus establish-
ing the tumor to be of Leydig cell subtype (Figure 4) [4,5].
The tumor capsule was intact and there was no evidence of
vascular invasion. Peritoneal fluid cytology did not reveal
any malignant cells. Intra-operatively, no significant
lymph nodes were noted. Thus, tumor was staged
T1N0M0. The preoperative elevated serum testosterone
level returned to normal. There was a gradual reversal of
her symptoms over time; however, the deep voice remains
persistent. The patient is being followed up on a regular
basis.
Discussion
Virilizing ovarian tumors account for less than 5% of all
ovarian neoplasms [6]. Sex cord-stromal tumors, are
derived from the sex cord and stromal components of
the developing gonad [4]. Steroid cell tumors are a subtype
of ovarian sex cord-stromal tumors that are composed
entirely of steroid-secreting cells and account for 0.1% of
all ovarian neoplasms [2]. Steroid cell tumors are usually
virilizing, frequently secreting testosterone; however, they
may be endocrinologically inert or estrogenic. As many
as one-quarter of steroid tumors exhibit malignant
behavior [4].
Steroid cell tumors are further subclassified into stromal
luteoma, Leydig cell tumors (hilar and nonhilar), and
steroid cell tumors that are not otherwise specific [7].
Most pure Leydig cell tumors of the ovary arise from
the hilus cells, or hilar-Leydig cells, which have the
morphologic features of testicular Leydig cells and
c a nb ef o u n di nt h eo v a r i a nh i l u si nm o r et h a n8 0 %
of adult women. These tumors are classified under the
category of steroid cell tumors (lipid cell tumors)
because they may be difficult or impossible to differ-
entiate histologically from ovarian tumors of other
steroid cell types [4].
Table 1. Laboratory investigations
Parameters Values
Hb 12.3 g/dl
Random blood sugar 96 mg/dl
TSH 2.56 mIU/ml
Estradiol 46 pg/dl
FSH 4.3 mIU/ml
LH 6.0 mIU/ml
Serum Cortisol < 1.0 mcg/dl
17 - hydroxyprogesterone 1.2 ng/dl
Serum Prolactin 10 ng/dl
Serum Testosterone Pre-operative
2300 ng/dl
Post-operative
72 ng/dl
Free Testosterone (pre-operative) 52 ng/dl 3.10 ng/dl
Figure 3. Macroscopic appearance of the ovarian mass.
Cut section of left ovary showing a solid, grey-tan color with
grey-brown patches.
Figure 4. Microscopic appearance of the ovarian mass.
A periodic acid-Schiff stained, histopathological specimen of
the ovarian tumor (100x magnification), showing crystalloids
of Reinke.
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by the age of presentation, hormonal activity, and
virilizing properties of the tumor. Virilization or hirsutism
is encountered with three fourths of Leydig cell tumors [7].
The clinical presentation may take many forms, including
abdominal pain, abdominal distention, and bloating.
However, the more noticeable presentations are those
associated with the hormonal activity and virilizing
properties of the tumor [8]. Signs and symptoms of
masculinizing tumors usually take place in two definite
phases, an early phase of defeminization and a subsequent
phase of masculinization. Typically, a menstruating
female will first notice oligomenorrhea or amenorrhea.
There is regression of the breasts and external genitalia,
atrophy of the uterus and adnexa, and loss of the female
body contour. This is followed by hirsutism, acne, clitoral
enlargement, increased libido, sterility, enlargement of the
larynx, deepening of the voice, and temporal alopecia
[9,10]. On the other hand, these tumors may produce little
or no androgenic activity and could, in fact, show some
evidence of estrogenic effect [4,10].
With regard to blood investigations, detecting the source
of the androgenic tumor is a process of exclusion. In our
patient, the high serum free and total testosterone
confirmed the presence of a virilizing neoplasm. A
dexamethasone suppression test failed to alter basal
values, moreover, 17-hydroxyprogesterone levels were
also within normal limits; this ruled out a potential
adrenal source of the androgens [11,12].
On radiological imaging, appearances of virilizing tumors
of the ovary depend, to some extent, on the tumor type.
Virilizing steroid cell tumors of the ovary are usually one
sided and often very small, measuring only slightly bigger
than the normal ovary [9,10]. They are usually confined to
the ovary at presentation, predominantly solid or mostly
solid, non-calcified, and not associated with ascites. Small
steroid cell tumors have been described as slightly
hypoechoic or hyperechoic (compared to the ovary) with
high diastolic flow on Doppler interrogation. They may be
difficult to identify on radiological imaging, in part
because they are isoechoic to the uterus on ultrasound
and isoattenuating on CT [13,14]. Techniques such as MRI
with phased array coils, or color Doppler imaging, can
possibly detect smaller tumors than more conventional
imaging methods [13,14,15]. In our patient, abdominal
ultrasound examination was unremarkable except for the
presence of ovarian cysts. A CT-scan and an MRI helped in
confirming the existence of a mass lesion involving the left
adnexa. It was the post-operative histopathological study,
however, that helped in clinching the final diagnosis as the
presence of Reinke’s crystalloid is diagnostic for Leydig cell
tumors [4,5,9].
Though steroid cell tumors of Leydig-cell subtype are
usually benign, there is still a potential risk for malignant
transformation [5,9,10]. Surgery remains the mainstay in
the management of these neoplasms as, in addition to
overcoming the above risk, however small, the removal of
the tumor is usually followed by near-complete regression
of the presenting symptoms. Initially, the signs of
defeminization, such as flattened breasts and loss of fat
around the hips, are reversed. Subsequent to this, the
virilizing effects disappear slowly; the hypertrophied
clitoris and the deepening of the voice, however,
frequently persist [6,10].
Conclusion
A patient who presents with virilism should be investi-
gated systematically to determine if the high testosterone
levels are of an adrenal or ovarian origin. In this patient,
hematological investigations ruled out an adrenal cause.
Radiological imaging proved to find that the cause of
virilization was of an ovarian etiology. Surgical interven-
tion was sought and the diagnosis of virilizing ovarian
tumor was made by histopathologic examination.
Patient’s perspective
It was a harrowing experience for me when I started
balding and growing excessive hair all over my body. My
fears increased as my friends and relatives started noticing
a change in my voice. When the doctors told me I had a
tumor, I felt my outcome was bleak. After the operation,
my physical appearance improved, and my social life has
returned to normal. I am grateful to the doctors for all they
have done.
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